$49.99
-1.43-2.78%
마지막 업데이트: Nov 3, 8:30 AM
Benzinga
Benzinga
Benzinga
화요일, 11월 03
Benzinga
© 2026 Benzinga | All Rights Reserved
CRISPR Therapeutics (CRSP) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-1.06 | $-1.18 | $-1.22 | $-1.20 |
| Actual | $-1.15 | $-0.94 | $-1.28 | $-1.37 |
| Surprise | -8.49% | +20.3% | -4.92% | -14.2% |
| Revenue | ||||
| Estimate | $15.2M | $7.1M | $5.1M | $3.9M |
| Actual | $12.7M | $10.2M | $1.5M | $864000 |
| Surprise | -16.9% | +43.0% | -71.2% | -78.0% |
| Metric | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|
| Earnings Per Share (Non-GAAP) | |||
| Consensus | $-1.17 | $-0.89 | $-0.86 |
| Revenue | |||
| Consensus | $16.0M | — | — |
| 회계 분기 | 보고된 날짜 | 실제 EPS | 예상 EPS | 놀라다 % |
|---|---|---|---|---|
| Q3 | Nov 2, 2026 | $-1.15 | $-1.06 | -8.49 % |
| Q2 | Aug 3, 2026 | $-0.94 | $-1.18 | 20.3 % |
| Q1 | May 4, 2026 | $-1.28 | $-1.22 | -4.92 % |
| Q4 | Feb 12, 2026 | $-1.37 | $-1.20 | -14.2 % |
| 회계 분기 | 보고된 날짜 | 실제 수익 | 예상 수익 | 놀라다 % |
|---|---|---|---|---|
| Q3 | Nov 2, 2026 | $12.67M | $15.24M | -16.9 % |
| Q2 | Aug 3, 2026 | $10.18M | $7.12M | 43.0 % |
| Q1 | May 4, 2026 | $1.46M | $5.06M | -71.2 % |
| Q4 | Feb 12, 2026 | $864.00K | $3.92M | -78.0 % |